Open Access. Powered by Scholars. Published by Universities.®
Antitrust and Trade Regulation Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- And Stockyards Administration; GIPSA; Elizabeth Warren; No-Poach; Joseph Biden; State Attorneys General; Clayton Act; Sherman Act; Donald Trump; Department of Justice; DOJ; Google; Apple; Amazon; White House; Time Warner/AT&T; Pharma; Pay-for-delay; generic drug; Preserve Access to Affordable Generics and Biosimilars Act; Section 5 of the FTC Act; Antitrust Review Act of 2019; Food and Agriculture Concentration and Market Power Review Commission; Reform Bills; Anti-Monopoly and Competition Restoration Act; AMCRA; Congressional Oversite; House Antitrust Caucus; globalization; income inequality; racial justice; NGO (1)
- Antitrust (1)
- Antitrust; Department of Justice; DOJ; Federal Trade Commission; FTC; Trump; Obama; Bush; Google; Facebook; marijuana; media; merger; think tanks; Open Markets Institute; Institute for Local Self-Reliance; The American Economic Liberties Project; competition law; second requests; cannabis; Department of Justice's Antitrust Division; ATR; William Barr; Office of Professional Responsibilitity; OPR; Disney-Fox; AT&T/Time Warner; merger; trade regulation; Controlled Substances Act; CSA; Hart-Scott-Rodino Act; HSR; threshold concern; enforcement; investigation; Clayton Act; Automakers; Greenhouse gas; environment; gas emission; Noerr-Pennington doctring; Roy Cohn; CARES Act; COVID-19; AI; neo-Brandeisian; technology; competition; anti-competitive; monopoly; duopoly; Android; iPhone; (1)
- Antitrust; European Union; Regan Revolution; Chicago School of Law and Economics; Campaign Platforms; COVID-19; Super Tuesday; Amy Klobuchar; United States Department of Agriculture; USDA; Office of Competition Advocate; OCA; Federal Trade Commission; FTC; Bernie Sanders; Federal Trade Commission Acts; Grain Inspectors (1)
- CMS (1)
-
- COVID-19 (1)
- Digital Health (1)
- Drug Price Competition and Patent Term Restoration Act of 1984; Hatch-Waxman Act; Prescription Drug Prices; Generic Drug Manufacturers; Generic Drug Application Process; Consumer Protection; Reverse Payments; Citizen Petitions; Product Hopping; Misclassiication of Drugs; Mylan Pharmaceuticals; EpiPen; Price Gouging; Food and Drug Administration; Generic Drug User Fee Amendments of 2012 (GDUFA); Sherman Antitrust Act; Monopilization of the Pharmaceutical Industry; New Drug Application (NDA); Brand-Name Drug Application Process; Abbreviated New Drug Application (ANDA); Exclusive Right to Market; Federal Trade commission Act (FTCA); Unfair Methods of Competition; "Unfair or Deceptive Acts or Practices"; "Pay-for-Delay"; Patent Infringement; FTC v. Actavis; Administrative Procedure Act (APA); "Eleventh Hour" Petitions; Medicaid and Medicare; "Innovator" and "Non-Innovator" Drugs; Schemes to Coerce Patients; "Soft Switch"; Pharmacy Benefit Managers (PBMs); Oversight Committees; Proposed Amendments; Reverse Payment Penalty; (1)
- Employment (1)
- Gig Economy (1)
- Health Policy (1)
- Healthcare (1)
- Labor (1)
- Liquidity systemic risk risk bankruptcy financial contract financial contract jurisdiction international domino microprudential macroprudential valuation netting collaterial disposal systemic uncertainty procyclicality froth privilege mitigation over-the-counter OTC Risk Global Financial crisis Best practice Bankruptcy Code EU Financial Collateral Arrangements Directive FCD Financial contract privilege Assets Funding Collective distress resolution Distressed estate Immunity Priority Legislative Guide Insolvency United Nations Commission on International Trade Law UNCITRAL Creditor Debtor World Bank Secured Credit UNIDROIT Close-out Unification Secured credit Financial system International Swaps and Deivatives Association ISDA Regulation Mitigation Systematic crisis Capital Financial institution Financial liberalization Market discipline Credit boom Asset price bubble Price bubble Leverage Lender Excessive leverage Debt Vulnerability Channel Amplifier Mortgage default Asset value contagion Bonds Knightian uncertainty Tranches Investment Default Countercyclical Liquid market ICR Standard International Monetary Fund IMF Immunity Welfare Fairness Preservation mechanism Distribution mechanism Pari passu Commercial Tax Bankruptcy moratorium Acceleration rights Set-off rights Pre-bankruptcy Transaction Enforcement International Adjustment Repos Collateral Rehypothecate Derivative Cleared derivative CPP Clearinghouse Over-the-counter OTC Credit default swap CFS Margining European Union EU Title transfer Security Financial collateral arrangement Risk mitigation Secured claims Borrow Security interest Counterparty risk Exponentiate Close-out Procyclical Rehypothecation Domino risk Financial crisis Bankruptcy Code Long-Term Capital Management LTCM Bankruptcy Abuse Prevention and Consumer Act BAPCA Variation margining (1)
- Multi-level marketing; consumer protection; pyramid scheme; FTC; LuLa Roe; Herbalife; Spreme Court; AMG Capital Management LLC v. FTC; Section 5; Section 19; Law; Policy; Enforcement; Lobbying; Administrative Law; Society (1)
- Packers (1)
- Platform Economy (1)
- Reproductive health; Hospital merger; Hospital mergers; Secular and nonsecular merger; secular and nonsecular mergers; Access to care; Full spectrum health care; Abortion access; Antitrust law; Sherman act; Clayton act; Merger guidelines; Protecting access to care; Health care (1)
- Technology (1)
Articles 1 - 7 of 7
Full-Text Articles in Antitrust and Trade Regulation
Big Dreams And Pyramid Schemes: The Ftc’S Path To Improving Multi-Level Marketing Consumer Protections In Light Of Amg Capital Management And The 2016 Herbalife Settlement, Camille H. Mangiaratti
Big Dreams And Pyramid Schemes: The Ftc’S Path To Improving Multi-Level Marketing Consumer Protections In Light Of Amg Capital Management And The 2016 Herbalife Settlement, Camille H. Mangiaratti
Journal of Law and Policy
Multi-level marketing, also known as “MLM,” is a type of sales business that relies on both sales to consumers and recruitment of sellers into the company’s tiered commission structure. MLMs are wildly and enduringly popular, especially because they claim to be a flexible and easy source of income for people who need it most. However, almost everyone who joins an MLM will lose money, and many MLMs are illegal pyramid schemes. Millions of Americans are harmed by MLMs every year. Despite this, the government does very little to punish MLMs who lie to prospective participants about their odds of success. …
Freedom Without Opportunity: Using Medicare Policy And Cms Mechanisms To Anticipate The Platform Economy’S Pitfalls And Ensure Healthcare Platform Workers Are Fairly Paid, Kim A. Aquino
Brooklyn Law Review
The rapidly aging population, along with the demand for innovative Medicare delivery models such as bundled payment programs have incentivized the use of technology in healthcare because of its potential to cut costs and improve quality of care. Like many industries embracing technological strides to automate and digitize services, the healthcare industry has welcomed new labor markets like the platform economy to facilitate connections between patients and workers with ease. Along with streamlining connections, the platform economy also promises workers flexibility and autonomy over their own schedule. The platform economy’s promise of freedom, however, is not enough to prevent the …
Shifting Antitrust Laws And Regulations In The Wake Of Hospital Mergers: Taking The Focus Off Of Elective Markets And Centering Health Care, Maya Inka Ureño-Dembar
Shifting Antitrust Laws And Regulations In The Wake Of Hospital Mergers: Taking The Focus Off Of Elective Markets And Centering Health Care, Maya Inka Ureño-Dembar
Brooklyn Law Review
Access to health care requires access to a care center and access to comprehensive health care services. Rampant hospital mergers are uniquely poised to reduce both the number of hospitals, requiring patients to travel further, and the services provided within a newly merged hospital, namely reproductive health services. This phenomenon is clearly seen through the merging of secular and nonsecular hospitals, which often result in patients being forced to travel much further for reproductive health care. In the United States’ current model, health care is not a right, but is treated as a commodity. As such, it is governed by …
The Political Face Of Antitrust, Spencer Weber Waller, Jacob E. Morse
The Political Face Of Antitrust, Spencer Weber Waller, Jacob E. Morse
Brooklyn Journal of Corporate, Financial & Commercial Law
The last twenty years have brought antitrust back to the fore as a political issue of greater salience. Several booms and busts in the economy have highlighted the issue of corporate power in the economy and the political system. The growing influence and aggressiveness of the European Union and other jurisdictions’ competition laws have highlighted the relative retreat in the United States. Political movements in the United States have brought issues of corporate power and its abuse back into the public limelight and with them a greater political salience for antitrust in the election cycle of 2020.
Two Politicizations Of U.S. Antitrust Law, Frank Pasquale, Jacqueline Green
Two Politicizations Of U.S. Antitrust Law, Frank Pasquale, Jacqueline Green
Brooklyn Journal of Corporate, Financial & Commercial Law
Critics have accused the Trump Department of Justice (DOJ) and Trump-appointee-chaired Federal Trade Commission (FTC) of populism, deviating from the more technocratic standards that governed agency interventions during the Bush and Obama eras. The broad brush of politicization has been applied to the administration's handling of a wide variety of topics, ranging from marijuana and media mergers, to landmark lawsuits against Google and Facebook. But a more discerning eye is necessary here. The concept of the political has both authoritarian and democratic registers. The federal Google and Facebook antitrust cases reflected the democratization of high technology antitrust. Meanwhile, troublingly authoritarian …
Abuse Of The Hatch-Waxman Act: Mylan's Ability To Monopolize Reflects Weaknesses, Kieran Meagher
Abuse Of The Hatch-Waxman Act: Mylan's Ability To Monopolize Reflects Weaknesses, Kieran Meagher
Brooklyn Journal of Corporate, Financial & Commercial Law
The Drug Price Competition and Patent Term Restoration Act of 1984, better known as the Hatch-Waxman Act, is intended to lower the average price paid by consumers for prescription drugs. The Hatch-Waxman Act attempts to do so by simplifying the application process for generic drug manufacturers, allowing generic drug applications to circumvent the lengthy FDA testing and approval process that brand-name manufacturers must undergo. Though the Hatch-Waxman Act has successfully created a clear path to the market for generic drugs, it contains loopholes that allow brand name and generic companies to engage in practices aimed at maximizing monopoly profits, effectively …
Liquidity, Systemic Risk, And The Bankruptcy Treatment Of Financial Contracts, Rizwaan J. Mokal
Liquidity, Systemic Risk, And The Bankruptcy Treatment Of Financial Contracts, Rizwaan J. Mokal
Brooklyn Journal of Corporate, Financial & Commercial Law
No abstract provided.